eli lilly and company retatrutide Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial A Study of Retatrutide (LY3437943)
Pay in 4 interest-free payments of $7.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2


























